You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Sandostatin

Showing 1 - 25 of 119
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer, Lymphocele Trial (Injection of sandostatine)

Terminated
  • Breast Cancer
  • Lymphocele
  • Injection of sandostatine
  • (no location specified)
Jul 26, 2022

Pancreatic Neuroendocrine Tumor G2 Trial (Octreotide LAR)

Completed
  • Pancreatic Neuroendocrine Tumor G2
  • Octreotide LAR
  • (no location specified)
Oct 17, 2023

Acromegaly Trial in Los Angeles (Pegvisomant, Octreotide LAR, Lanreotide)

Terminated
Has Results
  • Acromegaly
  • Los Angeles, California
    Cedars-Sinai Medical Center
Dec 12, 2022

Acromegaly Trial in Beijing (SYHX2008 injection, Octreotide Acetate Microspheres for Injection injection, Sandostatin ®

Recruiting
  • Acromegaly
  • SYHX2008 injection
  • +3 more
  • Beijing, Beijing, China
    Beijing Anzhen Hospital, Capital Medical University
Mar 13, 2023

Acromegaly: A Pattern of Treatment and Comparative Effectiveness

Recruiting
  • Acromegaly
  • Transnasal butterfly surgery
  • +2 more
  • Guangzhou, Guangdong, China
    China Acromegaly Organization
Mar 14, 2022

Tachycardia, Chronic Orthostatic Intolerance Trial in Nashville (drug, other, dietary supplement, radiation, procedure, device)

Active, not recruiting
  • Tachycardia
  • Chronic Orthostatic Intolerance
  • Nashville, Tennessee
    Vanderbilt University Autonomic Dysfunction Center
Sep 12, 2022

Pancreatic Cancer Trial in Liverpool (Blumgart Anastomosis, Cattell-Warren Anastomosis, Octreotide)

Active, not recruiting
  • Pancreatic Cancer
  • Blumgart Anastomosis
  • +2 more
  • Liverpool, Merseyside, United Kingdom
    Royal Liverpool University Hospital
Dec 8, 2021

Autosomal Dominant Polycystic Kidney Disease Trial in Ranica (Tolvaptan, Octreotide LAR, Placebo)

Completed
  • Autosomal Dominant Polycystic Kidney Disease
  • Ranica, Bergamo, Italy
    CRC per le Malattie Rare Aldo e Cele Daccò
Mar 10, 2022

Gastroenteropancreatic Neuroendocrine Tumor Trial in Belgium, Netherlands (Somatostatin analog)

Not yet recruiting
  • Gastroenteropancreatic Neuroendocrine Tumor
  • Somatostatin analog
  • Brasschaat, Antwerp, Belgium
  • +19 more
Jan 31, 2023

Neuroendocrine Tumors, Advanced Cancer Trial in Worldwide (Axitinib, Sandostatin LAR, Placebo)

Unknown status
  • Neuroendocrine Tumors
  • Advanced Cancer
  • Marburg, Germany
  • +25 more
Feb 1, 2021

Octreotide, Sputum Trial in Danbury (Octreotide)

Completed
Has Results
  • Octreotide
  • Sputum
  • Danbury, Connecticut
    Danbury Hospital
Sep 16, 2020

Malignant Carcinoid Syndrome Trial in Tampa (lanreotide Autogel (somatostatin analogue), Sandostatin long acting release (LAR)

Terminated
  • Malignant Carcinoid Syndrome
  • lanreotide Autogel (somatostatin analogue)
  • Sandostatin long acting release (LAR) Depot (somatostatin analogue)
  • Tampa, Florida
    Larry Kvols, MD
Apr 28, 2020

Carcinoma, Hepatocellular, Neuroendocrine Tumors Trial in Aarhus (Sorafenib, Radiofrequency ablation (RFA) or surgery,

Completed
  • Carcinoma, Hepatocellular
  • Neuroendocrine Tumors
  • Aarhus, Aarhus C, Denmark
    Department of Hepatology and Gastroenterology
Apr 27, 2021

Acromegaly Trial in Worldwide (Pasireotide)

Completed
Has Results
  • Acromegaly
  • Los Angeles, California
  • +9 more
Sep 1, 2021

Neuroendocrine Tumors Trial in China (Lutetium[177Lu] Oxodotreotide Injection, Octreotide LAR)

Not yet recruiting
  • Neuroendocrine Tumors
  • Lutetium[177Lu] Oxodotreotide Injection
  • Octreotide LAR
  • Beijing, Beijing, China
  • +20 more
Jul 25, 2022

Neuroendocrine Tumors, Carcinoid Syndrome Trial (Sandostatin)

Terminated
  • Neuroendocrine Tumors
  • Carcinoid Syndrome
  • Sandostatin
  • (no location specified)
Oct 24, 2019

Acromegaly, GEP-NET Trial in Worldwide (Debio 4126, Sandostatin LAR, Somatuline ATG)

Recruiting
  • Acromegaly
  • GEP-NET
  • Debio 4126
  • +2 more
  • Copenaghen, Denmark
  • +34 more
Jan 27, 2023

Stress, Diurnal Cortisol, and Breast Cancer Survival

Completed
  • Breast Cancer
  • Sandostatin
  • Stanford, California
    Stanford University School of Medicine
Jan 23, 2020

Prader Willis Syndrome Trial (Placebo, Octreotide)

Unknown status
  • Prader Willis Syndrome
  • (no location specified)
Aug 5, 2019

Tumors Trial in Worldwide (Everolimus, Sandostatin LAR Depot)

Completed
Has Results
  • Neoplasms
  • Little Rock, Arkansas
  • +23 more
May 17, 2021

Carcinoid Tumor of the Small Bowel, Neuroendocrine Tumour Trial in Worldwide (Octreotide LAR, 177Lu-DOTA0-Tyr3-Octreotate)

Completed
Has Results
  • Carcinoid Tumor of the Small Bowel
  • Neuroendocrine Tumour
  • Los Angeles, California
  • +38 more
Mar 10, 2022

Esophageal Cancer, Gastric Cancer Trial in Stockholm (Octreotide Injection)

Recruiting
  • Esophageal Cancer
  • Gastric Cancer
  • Octreotide Injection
  • Stockholm, Sweden
    Karolinska University Hospital, Huddinge
Aug 16, 2022

Acromegaly Trial in Tempe (ONO-5788, ONO-5788 Placebo, Octreotide)

Terminated
  • Acromegaly
  • Tempe, Arizona
    Celerion
Jun 3, 2019

Small Bowel Carcinoid Tumor Trial in Boston (drug, device, other)

Withdrawn
  • Small Bowel Carcinoid Tumor
  • Boston, Massachusetts
  • +1 more
Jun 19, 2019

Hepatic Carcinoma, Hepatic Metastasis Trial in Pamplona (Octreotide, Placebo)

Recruiting
  • Hepatic Carcinoma
  • Hepatic Metastasis
  • Pamplona, Spain
    Clinica Universidad de Navarra
Oct 10, 2023